Diseases, Conditions, Syndromes

Experts meet in Geneva to review Ebola vaccines: WHO

Experts will gather in Geneva this week to review progress on possible vaccines against the deadly Ebola virus, the World Health Organization said Wednesday.

Medications

Judge halts Alzheimer's drug swap until July

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

Medications

Pricing for new drugs lacks transparency

The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal ...

Health

Impact of physician payments sunshine act discussed

(HealthDay)—The Physician Payments Sunshine Act is causing concern for manufacturers and providers, as well as physicians, according to a health policy brief published online Oct. 2 in Health Affairs.

Health

Gov't website for doc payments not up to snuff

The government's new "Open Payments" website is intended to let you find out whether your doctor is getting freebies, travel or other financial benefits from drug companies and medical device manufacturers. But it doesn't ...

Medications

Perampanel for epilepsy: Still no proof of added benefit

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

page 31 from 40